日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Expanding the cytokine receptor alphabet reprograms T cells into diverse states

扩展细胞因子受体库可将T细胞重编程为多种状态。

Yang Zhao ,Masato Ogishi ,Aastha Pal ,Leon L Su ,Pingdong Tao ,Hua Jiang ,Grayson E Rodriguez ,Xiaojing Chen ,Qinli Sun ,Lea Wenting Rysavy ,Sam Limsuwannarot ,Deepa Waghray ,Anusha Kalbasi ,K Christopher Garcia

Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors

金-siRNA超簇增强立体定向消融放射疗法对原发性和转移性肿瘤的抗肿瘤免疫反应

Yuyan Jiang ,Hongbin Cao ,Huaping Deng ,Li Guan ,Jimpi Langthasa ,Deana Rae Crystal Colburg ,Stavros Melemenidis ,Renee M Cotton ,John Aleman ,Xiao-Jing Wang ,Edward E Graves ,Anusha Kalbasi ,Kanyi Pu ,Jianghong Rao ,Quynh-Thu Le

IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapy

IL-9 作为一种天然正交细胞因子,具有最佳的 JAK/STAT 信号通路活性,可用于工程化 T 细胞治疗。

Hua Jiang ,Sam Limsuwannarot ,Kayla R Kulhanek ,Aastha Pal ,Ossama Labiad ,Lea W Rysavy ,Ada Wong ,Leon Su ,Sarah Cavender ,Johnathon Soro ,Stefano Testa ,Heather Ogana ,Deepa Waghray ,Pingdong Tao ,Kevin M Jude ,Christopher S Seet ,Gay M Crooks ,Everett J Moding ,K Christopher Garcia ,Anusha Kalbasi

Antitumor Immune Responses in B2M-Deficient Cancers

B2M缺陷型癌症中的抗肿瘤免疫反应

Davis Y Torrejon # ,Mildred Galvez # ,Gabriel Abril-Rodriguez ,Katie M Campbell ,Egmidio Medina ,Agustin Vega-Crespo ,Anusha Kalbasi ,Begoña Comin-Anduix ,Antoni Ribas

Adaptation of the Tumor Antigen Presentation Machinery to Ionizing Radiation

肿瘤抗原呈递机制对电离辐射的适应

Mi-Heon Lee ,Duang Ratanachan ,Zitian Wang ,Jacob Hack ,Lobna Adbulrahman ,Nicholas P Shamlin ,Mirna Kalayjian ,Jean Philippe Nesseler ,Ekambaram Ganapathy ,Christine Nguyen ,Josephine A Ratikan ,Nicolas A Cacalano ,David Austin ,Robert Damoiseaux ,Benjamin J DiPardo ,Danielle S Graham ,Anusha Kalbasi ,James W Sayre ,William H McBride ,Dörthe Schaue

IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma

IGF2BP3 作为高分化/去分化脂肪肉瘤的预后生物标志物

Kyle D Klingbeil, Jack Pengfei Tang, Danielle S Graham, Serena Y Lofftus, Amit Kumar Jaiswal, Tasha L Lin, Chris Frias, Lucia Y Chen, Manando Nakasaki, Sarah M Dry, Joseph G Crompton, Fritz C Eilber, Dinesh S Rao, Anusha Kalbasi, Brian E Kadera

Potentiating adoptive cell therapy using synthetic IL-9 receptors

利用合成 IL-9 受体增强过继细胞疗法

Anusha Kalbasi #, Mikko Siurala #, Leon L Su #, Mito Tariveranmoshabad, Lora K Picton, Pranali Ravikumar, Peng Li, Jian-Xin Lin, Helena Escuin-Ordinas, Tong Da, Sarah V Kremer, Amy L Sun, Sofia Castelli, Sangya Agarwal, John Scholler, Decheng Song, Philipp C Rommel, Enrico Radaelli, Regina M Young, 

Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy

空间分析揭示了滑膜肉瘤对 NY-ESO-1 转基因 T 细胞疗法获得性耐药中 WNT 通路激活与 T 细胞排斥之间的关联

Katie M Campbell, Maneesha Thaker, Egmidio Medina, Anusha Kalbasi, Arun Singh, Antoni Ribas, Theodore Scott Nowicki0

Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy

IL13 变体工程化直接影响 IL13Rα2 靶向 CAR-T 细胞疗法的特异性

Lawrence A Stern, Sharareh Gholamin, Ignacio Moraga, Xin Yang, Supraja Saravanakumar, Joseph R Cohen, Renate Starr, Brenda Aguilar, Vanessa Salvary, Jonathan C Hibbard, Anusha Kalbasi, Jennifer K Shepphird, James O'Hearn, K Christopher Garcia, Christine E Brown

Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade

克服 PD-1 阻断的遗传性耐药机制

Davis Y Torrejon, Gabriel Abril-Rodriguez, Ameya S Champhekar, Jennifer Tsoi, Katie M Campbell, Anusha Kalbasi, Giulia Parisi, Jesse M Zaretsky, Angel Garcia-Diaz, Cristina Puig-Saus, Gardenia Cheung-Lau, Thomas Wohlwender, Paige Krystofinski, Agustin Vega-Crespo, Christopher M Lee, Pau Mascaro, Cat